Who was studied, and how
Four numbers in the abstract
Where each one falls
Where it lands on the map
900people in the Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in Acute Myocardial Infarction trial, from 2015
418of them with cardiovascular disease, in this paper
The trial randomly assignedassigned by chance
pitavastatin 4 mg
atorvastatin 20 mg or 40 mg
No clear effect on adjusted mean treatment differences for pitavastatin vs. atorvastatin [in LDL-C]+0.11
randomisedthe abstract, start to end
… the non-inferiority margin at weeks 16 (+0.11%; 95% confidence interval (CI), -5.23 to 5.44) and 44 (-0.02%; 95% CI, -5.46 to 5.41) of the …
… fasting blood glucose from baseline (+7.2%; p < 0.05), whereas pitavastatin had no significant effect (+2.1%).
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
Adjusted mean treatment differences for pitavastatin vs. atorvastatin [in LDL-C]pitavastatin 4 mg vs atorvastatin 20 mg or 40 mg
0.11−5.23 to 5.44
Adjusted mean treatment differences for pitavastatin vs. atorvastatin [in LDL-C]pitavastatin 4 mg vs atorvastatin 20 mg or 40 mg
−0.02−5.46 to 5.41
Fasting blood glucose from baselineatorvastatin
7.2
Fasting blood glucose from baselinepitavastatin
2.1
StatinsGlycemic controlLipids
1 / 4